
Mindbio Therapeutics Corp.
MBIO·CSE
Last updated as of 2026-02-28 22:27 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
MBIO stock price change
On the last trading day, MBIO stock closed at 0.96 CAD, with a price change of 6.67% for the day.
Trade stock perpsTrending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreMBIO key data
Previous close0.96 CAD
Market cap1.96M CAD
Volume9.80K
P/E ratio-
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)-5.75 CAD
Net income (FY)−2.53M CAD
Revenue (FY)0.00 CAD
Next report date-
EPS estimate-
Revenue estimate-
Shares float—
Beta (1Y)5.07

Mindbio Therapeutics Corp. overview
MindBio Therapeutics Corp. engages in the development of psychedelic substances for mental health conditions. It also researches novel and clinically proven treatments for depression, anxiety, PTSD, and chronic pain. The company was founded by Justin Adam Hanka in 2019 and is headquartered in Vancouver, Canada.
Sector
Health technology
Industry
Pharmaceuticals: Major
CEO
Justin Adam Hanka
Headquarters
Vancouver
Website
mindbiotherapeutics.com
Founded
2019
Employees (FY)
-
Change (1Y)
-
Revenue / Employee (1Y)
-
Net income / Employee (1Y)
-
MBIO stock price forecast
According to technical indicators for MBIO stock, the price is likely to fluctuate within the range of 0.91–1.11 CAD over the next week. Market analysts predict that the price of MBIO stock will likely fluctuate within the range of 0.87–1.44 CAD over the next months.
Based on 1-year price forecasts from 22 analysts, the highest estimate is 1.99 CAD, while the lowest estimate is 0.64 CAD.
For more information, please see the
MBIO stock price forecast
page.




